Doctor showing images on Philips Enterprise Viewer
Amsterdam, the Netherlands and South Carolina, USA, April 28 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Prisma Health, South Carolina’s largest non-profit healthcare system, today announced they have entered into a multi-year agreement to help the health system achieve enterprise interoperability, standardize patient monitoring, and drive innovation in enterprise imaging solutions to enhance patient care and improve clinical performance. As South Carolina’s largest private, non-profit healthcare system, and second-largest private company, Prisma Health wants to deliver on the quadruple aim: improve patient and staff satisfaction, lower costs, and improve outcomes for all South Carolinians.
Prisma Health was formed in 2017 when Greenville Health System and Palmetto Health, two of South Carolina’s most highly regarded healthcare systems, came together as one organization. Today, Prisma Health has nearly 3,000 licensed beds and 18 acute care and specialty hospitals, as well as 270 physician practices servicing 21 counties. They treat over one million unique patients across their networks each year, including 368,000 virtual care visits, and just under half a million emergency department visits.
“When our two regional healthcare organizations merged, an enterprise-wide technology strategy became critical to standardize best practices across the whole system, creating new bridges between hospital and home care and continuing to drive innovation,” said Rich Rogers, Senior Vice President, Chief Information Officer, Prisma Health. “At Prisma Health, we wanted to engage a partner to help us address data integration and unlock the power of patient data so that we are able to provide our patients with the best care anywhere in our service areas. We want to put the right tools into the hands of our clinicians to allow them to better share information, collaborate and help transform care for the communities we serve.”
With the Philips HealthSuite secure cloud platform at its foundation, Philips is committed to enterprise interoperability. Philips’ solutions portfolio includes real-time patient monitoring, therapeutic devices, telehealth, image management and informatics solutions including radiology and cardiology PACS, advanced visualization, vendor neutral archive (VNA) and Philips Enterprise Viewer – Vue Motion, and interoperability solutions, including the industry-leading Philips Capsule Medical Device Information Platform. Prisma Health will not only have access to these technologies, they will also be the largest installation of the Philips Enterprise Performance Analytics – Performance Bridge – analytics platform in North America. Performance Bridge gives healthcare professionals access to near real-time data on departmental performance through an easy-to-use interactive dashboard. Vendor agnostic, Performance Bridge unifies information across different imaging modalities and informatics solutions to optimize organizational efficiency, drive adherence to standards of care and facilitates additional revenue streams. Prisma Health plans to use Performance Bridge to drive innovation and monitor their delivery of quality healthcare.
“At Philips, we made a deliberate decision to create an end-to-end enterprise strategy that will help our customers overcome interoperability barriers and enable data sharing,” said Vitor Rocha, Chief Market Leader for Philips North America. “Health systems shouldn’t have to worry about integrating technology, which is why we have developed vendor-agnostic solutions based on standards and frameworks that bring together data from applications, systems, and devices. This allows our partners to focus on what is most important to them and their patients – continuously improving the patient journey and outcomes.”
Long-term strategic partnerships (LSPs) are a growing trend within hospitals and health systems to better manage the cost and complexity of their technology investments over a defined period of time, while expanding quality access to advanced medical care to improve patient outcomes. Philips is a leader in LSPs and continues to work with forward-thinking organizations like Prisma Health to develop standards, best practices, and predictive technologies that can redefine the future of healthcare.
For further information, please contact:
Mark Groves
Philips Global Press Office
Tel.: +31 631 639 916
E-mail: mark.groves@philips.com
Silvie Casanova
Philips North America
Tel.: +1 781 879 0692
E-mail: silvie.casanova@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
About Prisma Health
Prisma Health is a non-profit health company and the largest healthcare system in South Carolina. With nearly 30,000 team members, 18 acute and specialty hospitals, 2,947 beds and more than 300 outpatient sites with nearly 2,000 physicians, Prisma Health serves more than 1.5 million unique patients annually in its 21-county market area that covers 50% of South Carolina. Prisma Health’s goal is to improve the health of all South Carolinians by enhancing clinical quality, the patient experience and access to affordable care, as well as conducting clinical research and training the next generation of medical professionals. Visit PrismaHealth.org for more information.
Attachment
Source: Philips International B.V. via GLOBE NEWSWIRE
